Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Sponsor: National Institute of Neurology and Neurosurgery, Mexico
A PHASE4 clinical study on Depressive Disorder, Treatment-Resistant, this trial is ongoing. The trial is conducted by National Institute of Neurology and Neurosurgery, Mexico and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurology and Neurosurgery, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .